Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute liver failure
MedTech
Baxter, Miromatrix test bioengineered liver replacement therapy
Miromatrix currently awaits a green light from the FDA to launch a phase 1 study, after a clinical hold and requests for additional data.
Conor Hale
Feb 1, 2023 11:44am
Anti-aging for the liver? Study finds way to de-age liver cells
May 2, 2022 6:00am
Novartis taps Alnylam for ambitious push to fix liver function
Jan 6, 2022 8:00am
Versantis raises cash to take liver failure drug to clinical POC
Sep 18, 2019 1:00am
Madrigal’s NASH drug hits liver fat in midstage test
Dec 6, 2017 7:47am
